Abstract
Background: Trifluridine/tipiracil (TAS-102, Lonsurf (R)), a novel oral anti-tumor agent combining an anti-neoplastic thymidine-based nucleoside analo......
小提示:本篇文献需要登录阅读全文,点击跳转登录